Diabetologia

Nice insulins, pity about the evidence
pp. 1783-1790(8)
Authors: Holleman, F.; Gale, E.

The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
pp. 1791-1794(4)
Author: Halban, P.

A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease
pp. 1795-1807(13)
Authors: Lindeberg, S.; Jönsson, T.; Granfeldt, Y.; Borgstrand, E.; Soffman, J.; Sjöström, K.; Ahrén, B.

Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes
pp. 1808-1814(7)
Authors: Gordin, D.; Rönnback, M.; Forsblom, C.; Heikkilä, O.; Saraheimo, M.; Groop, P.-H.

A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes
pp. 1815-1818(4)
Authors: Bussau, V.; Ferreira, L.; Jones, T.; Fournier, P.

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes
pp. 1819-1825(7)
Authors: Tan, K.; Chow, W.; Tso, A.; Xu, A.; Tse, H.; Hoo, R.; Betteridge, D.; Lam, K.

School marks for Swedish children whose mothers had diabetes during pregnancy: a population-based study
pp. 1826-1831(6)
Authors: Dahlquist, G.; Källén, B.

Independent associations of physical activity and cardiorespiratory fitness with metabolic risk factors in children: the European youth heart study
pp. 1832-1840(9)
Authors: Ekelund, U.; Anderssen, S.; Froberg, K.; Sardinha, L.; Andersen, L.; Brage, S.

Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002
pp. 1841-1851(11)
Authors: Lee, D.-H.; Lee, I.-K.; Porta, M.; Steffes, M.; Jacobs, D.

Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men
pp. 1852-1857(6)
Authors: Dahlgren, A.; Zethelius, B.; Jensevik, K.; Syvänen, A.-C.; Berne, C.

Variations in the four and a half LIM domains 1 gene (FHL1) are associated with fasting insulin and insulin sensitivity responses to regular exercise
pp. 1858-1866(9)
Authors: Teran-Garcia, M.; Rankinen, T.; Rice, T.; Leon, A.; Rao, D.; Skinner, J.; Bouchard, C.

Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice
pp. 1867-1879(13)
Authors: Toye, A.; Dumas, M.; Blancher, C.; Rothwell, A.; Fearnside, J.; Wilder, S.; Bihoreau, M.; Cloarec, O.; Azzouzi, I.; Young, S.; Barton, R.; Holmes, E.; McCarthy, M.; Tatoud, R.; Nicholson, J.; Scott, J.; Gauguier, D.

Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome?
pp. 1880-1888(9)
Authors: Benyamin, B.; Sørensen, T.; Schousboe, K.; Fenger, M.; Visscher, P.; Kyvik, K.

Morphological localisation of sulfonylurea receptor 1 in endocrine cells of human, mouse and rat pancreas
pp. 1889-1899(11)
Authors: Guiot, Y.; Stevens, M.; Marhfour, I.; Stiernet, P.; Mikhailov, M.; Ashcroft, S.; Rahier, J.; Henquin, J.-C.; Sempoux, C.

Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes
pp. 1900-1909(10)
Authors: Zhang, J.; Tokui, Y.; Yamagata, K.; Kozawa, J.; Sayama, K.; Iwahashi, H.; Okita, K.; Miuchi, M.; Konya, H.; Hamaguchi, T.; Namba, M.; Shimomura, I.; Miyagawa, J-i.

Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy
pp. 1910-1920(11)
Authors: Ren, B.; O'Brien, B.; Swan, M.; Koina, M.; Nassif, N.; Wei, M.; Simpson, A.

Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study
pp. 1921-1929(9)
Authors: Chokkalingam, K.; Tsintzas, K.; Snaar, J.; Norton, L.; Solanky, B.; Leverton, E.; Morris, P.; Mansell, P.; Macdonald, I.

Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease
pp. 1930-1937(8)
Authors: Eynatten, M.; Lepper, P.; Liu, D.; Lang, K.; Baumann, M.; Nawroth, P.; Bierhaus, A.; Dugi, K.; Heemann, U.; Allolio, B.; Humpert, P.

Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification
pp. 1938-1948(11)
Authors: Ouwens, D.; Diamant, M.; Fodor, M.; Habets, D.; Pelsers, M.; Hasnaoui, M.; Dang, Z.; Brom, C.; Vlasblom, R.; Rietdijk, A.; Boer, C.; Coort, S.; Glatz, J.; Luiken, J.

l-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity
pp. 1949-1959(11)
Authors: Prada, P.; Hirabara, S.; Souza, C.; Schenka, A.; Zecchin, H.; Vassallo, J.; Velloso, L.; Carneiro, E.; Carvalheira, J.; Curi, R.; Saad, M.

Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism
pp. 1960-1968(9)
Authors: Han, R.; Lai, R.; Ding, Q.; Wang, Z.; Luo, X.; Zhang, Y.; Cui, G.; He, J.; Liu, W.; Chen, Y.

Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes
pp. 1969-1976(8)
Authors: Jamieson, H.; Cogger, V.; Twigg, S.; McLennan, S.; Warren, A.; Cheluvappa, R.; Hilmer, S.; Fraser, R.; Cabo, R.; Couteur, D.

Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy
pp. 1977-1986(10)
Authors: Linthout, S.; Riad, A.; Dhayat, N.; Spillmann, F.; Du, J.; Dhayat, S.; Westermann, D.; Hilfiker-Kleiner, D.; Noutsias, M.; Laufs, U.; Schultheiss, H.-P.; Tschöpe, C.

Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes
pp. 1987-1996(10)
Authors: Zheng, L.; Du, Y.; Miller, C.; Gubitosi-Klug, R.; Kern, T.; Ball, S.; Berkowitz, B.

Ablation of the gene encoding p66^Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation
pp. 1997-2007(11)
Authors: Menini, S.; Iacobini, C.; Ricci, C.; Oddi, G.; Pesce, C.; Pugliese, F.; Block, K.; Abboud, H.; Giorgio, M.; Migliaccio, E.; Pelicci, P.; Pugliese, G.

Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells
pp. 2008-2018(11)
Authors: Wu, D.; Peng, F.; Zhang, B.; Ingram, A.; Gao, B.; Krepinsky, J.

Mutations in HHEX are not a common cause of monogenic forms of beta cell dysfunction
pp. 2019-2022(4)
Authors: Minton, J.; Bunt, M.; Boustred, C.; Hussain, K.; Hattersley, A.; Ellard, S.; Gloyn, A.

Comment on: Holt HB, Wild SH, Postle AD et al (2007) Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men. Diabetologia 50:1024-1032
pp. 2023-2024(2)
Authors: Kerstens, M.; Dullaart, R.

Insulin resistance and cortisol metabolism. Reply to Kerstens MN, Dullaart RPF [letter]
pp. 2025-2026(2)
Authors: Byrne, C.; Wild, S.; Phillips, D.; Holt, H.

Brain derived neurotrophic factor (BDNF) release from the human brain in patients with type 2 diabetes—possible influence of venous anatomy and comorbid major depressive disorder
pp. 2027-2028(2)
Authors: Lambert, G.; Schlaich, M.; Esler, M.

Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Reply to Lambert GW et al (letter)
pp. 2029-2030(2)
Authors: Krabbe, K.; Nielsen, A.; Krogh-Madsen, R.; Plomgaard, P.; Rasmussen, P.; Erikstrup, C.; Fischer, C.; Lindegaard, B.; Petersen, A.; Taudorf, S.; Secher, N.; Pilegaard, H.; Bruunsgaard, H.; Pedersen, B.

Human Krüppel-like factor 11 inhibits human proinsulin promoter activity in pancreatic beta cells
pp. 2031-2031(1)
Authors: Niu, X.; Perakakis, N.; Laubner, K.; Limbert, C.; Stahl, T.; Brendel, M.; Bretzel, R.; Seufert, J.; Päth, G.